Selection of candidates for cardiac resynchronization therapy and implantation management: an Italian survey promoted by the Italian Association of Arrhythmology and Cardiac Pacing.

IF 2.9 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Matteo Ziacchi, Matteo Anselmino, Pietro Palmisano, Michela Casella, Gemma Pelargonio, Vincenzo Russo, Antonio D'Onofrio, Giulia Massaro, Manola Vilotta, Maurilio Lauretti, Sakis Themistoclakis, Giuseppe Boriani, Roberto De Ponti
{"title":"Selection of candidates for cardiac resynchronization therapy and implantation management: an Italian survey promoted by the Italian Association of Arrhythmology and Cardiac Pacing.","authors":"Matteo Ziacchi, Matteo Anselmino, Pietro Palmisano, Michela Casella, Gemma Pelargonio, Vincenzo Russo, Antonio D'Onofrio, Giulia Massaro, Manola Vilotta, Maurilio Lauretti, Sakis Themistoclakis, Giuseppe Boriani, Roberto De Ponti","doi":"10.2459/JCM.0000000000001650","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cardiac resynchronization therapy (CRT) represents an effective heart failure treatment, associated with reduction in mortality and heart failure hospitalizations. This Italian survey aimed to address relevant CRT issues.</p><p><strong>Methods: </strong>An online survey was administered to AIAC members.</p><p><strong>Results: </strong>One hundred and five electrophysiologists participated, with a median of 40 (23-70) CRT implantations/year (33% in high-volume centres). Forty-five percent of respondents (especially working in high-volume centres) reported an increase in CRT implantations in the last 2 years, in 16% a decrease, and in 38% CRT remained stable. Seventy-five percent of respondents implanted CRT only in patients with European Heart Rhythm Association (EHRA) class I indications. All operators collected ECG and echocardiography before implantation. Eighty-five percent of respondents selected coronary sinus target vein empirically, whereas 10% used mechanical and/or electrical delay techniques. Physicians working in high-volume centres reported a lower failure rate compared with others (16 vs. 34%; P = 0.03). If the coronary sinus lead could not be positioned in the target branch, 80% placed it in another vein, whereas 16% opted for a surgical approach or for conduction system pacing (CSP). Eighty percent accomplished CRT optimization in all patients, 17% only in nonresponders. Regarding anticoagulation, high agreement with EHRA guidelines emerged.</p><p><strong>Conclusion: </strong>CRT represents a valid therapeutic option in heart failure treatment. Nowadays, CRT implantations remain stable and are mainly performed in patients with class I indications. ECG remains the preferred tool for patient selection, whereas imaging is increasingly used to determine the left pacing target area. In most patients, the left ventricular lead can be successfully positioned in the target vein, but in some cases, the result can be unsatisfactory; however, the decision to explore alternative resynchronization approaches is rarely pursued.</p>","PeriodicalId":15228,"journal":{"name":"Journal of Cardiovascular Medicine","volume":" ","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiovascular Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2459/JCM.0000000000001650","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Cardiac resynchronization therapy (CRT) represents an effective heart failure treatment, associated with reduction in mortality and heart failure hospitalizations. This Italian survey aimed to address relevant CRT issues.

Methods: An online survey was administered to AIAC members.

Results: One hundred and five electrophysiologists participated, with a median of 40 (23-70) CRT implantations/year (33% in high-volume centres). Forty-five percent of respondents (especially working in high-volume centres) reported an increase in CRT implantations in the last 2 years, in 16% a decrease, and in 38% CRT remained stable. Seventy-five percent of respondents implanted CRT only in patients with European Heart Rhythm Association (EHRA) class I indications. All operators collected ECG and echocardiography before implantation. Eighty-five percent of respondents selected coronary sinus target vein empirically, whereas 10% used mechanical and/or electrical delay techniques. Physicians working in high-volume centres reported a lower failure rate compared with others (16 vs. 34%; P = 0.03). If the coronary sinus lead could not be positioned in the target branch, 80% placed it in another vein, whereas 16% opted for a surgical approach or for conduction system pacing (CSP). Eighty percent accomplished CRT optimization in all patients, 17% only in nonresponders. Regarding anticoagulation, high agreement with EHRA guidelines emerged.

Conclusion: CRT represents a valid therapeutic option in heart failure treatment. Nowadays, CRT implantations remain stable and are mainly performed in patients with class I indications. ECG remains the preferred tool for patient selection, whereas imaging is increasingly used to determine the left pacing target area. In most patients, the left ventricular lead can be successfully positioned in the target vein, but in some cases, the result can be unsatisfactory; however, the decision to explore alternative resynchronization approaches is rarely pursued.

心脏再同步化疗法候选者的选择和植入管理:意大利心律失常和心脏起搏协会发起的意大利调查。
背景:心脏再同步化疗法(CRT)是一种有效的心衰治疗方法,可降低死亡率和心衰住院率。这项意大利调查旨在解决 CRT 的相关问题:方法:对 AIAC 成员进行在线调查:结果:有 15 位电生理学家参与了调查,他们的 CRT 植入中位数为每年 40 例(23-70 例)(33% 在高容量中心)。45%的受访者(尤其是在高容量中心工作的受访者)报告说,在过去两年中,CRT 植入数量有所增加,16%的受访者报告说,CRT 植入数量有所减少,38%的受访者报告说,CRT 植入数量保持稳定。75%的受访者仅为具有欧洲心脏节律协会(EHRA)I级适应症的患者植入CRT。所有操作人员都在植入前采集了心电图和超声心动图。85%的受访者根据经验选择冠状窦靶静脉,10%的受访者使用机械和/或电延迟技术。在大容量中心工作的医生与其他医生相比,失败率较低(16% 对 34%;P = 0.03)。如果冠状窦导联无法定位在目标分支,80% 的医生会将其放置在另一条静脉中,而 16% 的医生会选择外科手术或传导系统起搏 (CSP)。80%的患者完成了 CRT 优化,17%的患者只完成了无反应者的优化。在抗凝方面,与 EHRA 指南的一致性很高:CRT是治疗心衰的有效方法。结论:CRT 是心力衰竭治疗中的有效治疗方案。目前,CRT 植入术保持稳定,主要用于 I 类适应症患者。心电图仍是选择患者的首选工具,而成像技术则越来越多地用于确定左起搏靶区。在大多数患者中,左心室导联可以成功定位在靶静脉中,但在某些情况下,结果可能并不令人满意;不过,很少有人会决定探索其他再同步化方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Cardiovascular Medicine
Journal of Cardiovascular Medicine 医学-心血管系统
CiteScore
3.90
自引率
26.70%
发文量
189
审稿时长
6-12 weeks
期刊介绍: Journal of Cardiovascular Medicine is a monthly publication of the Italian Federation of Cardiology. It publishes original research articles, epidemiological studies, new methodological clinical approaches, case reports, design and goals of clinical trials, review articles, points of view, editorials and Images in cardiovascular medicine. Submitted articles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editors and those invited to do so from a reviewer pool. ​
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信